Phase 2 Trial of RM-1929 With Photoimmunotherapy for Head and Neck Cancer - Cancer Therapy Advisor

Cancer Therapy Advisor

Phase 2 Trial of RM-1929 With Photoimmunotherapy for Head and Neck Cancer Cancer Therapy Advisor ... phase 1/2, multi-center trial, researchers are evaluating the safety and efficacy of RM-1929, a "chemical conjugate composed of the dye IR700 linked to cetuximab," combined with an activating near-infrared light, for patients with head and neck ...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uaRRQQ
via IFTTT